Maven Securities LTD Grifols Sa Transaction History

Maven Securities LTD

$774 Million
Q3 2024

A detailed history of Maven Securities LTD transactions in Grifols Sa stock. As of the latest transaction made, Maven Securities LTD holds 28,136 shares of GRFS stock, worth $206,799. This represents 0.03% of its overall portfolio holdings.

Number of Shares

28,136

Holding current value

$206,799

% of portfolio

0.03%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$6.28 - $9.38 $176,694 - $263,915	28,136 New	28,136 $249,000
Q1 2022 May 16, 2022	SELL	$10.37 - $12.73 $1.23 Million - $1.51 Million	-118,805 Reduced 60.07%	78,978 $922,000
Q4 2021 Feb 14, 2022	BUY	$10.21 - $15.27 $1.51 Million - $2.25 Million	147,665 Added 294.63%	197,783 $2.22 Million
Q3 2021 Nov 15, 2021	BUY	$14.07 - $17.3 $705,160 - $867,041	50,118 New	50,118 $732,000
Q1 2020 May 15, 2020	SELL	$16.28 - $25.63 $397,769 - $626,217	-24,433 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$19.85 - $22.76 $13,120 - $15,044	661 Added 2.78%	24,433 $493,000
Q2 2019 Aug 13, 2019	BUY	$17.59 - $21.1 $418,149 - $501,589	23,772 New	23,772 $494,000
Q4 2017 Feb 08, 2018	SELL	$20.99 - $23.89 $2.11 Million - $2.4 Million	-100,377 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$20.07 - $21.89 $2.01 Million - $2.2 Million	100,377	100,377 $2.21 Million

Others Institutions Holding GRFS

# of Institutions

164

Shares Held

140M

Call Options Held

288K

Put Options Held

389K

Capital World Investors Los Angeles, CA

21M
Shares

$154 Million
0.03% of portfolio
Brandes Investment Partners, LP La Jolla, CA

19.9M
Shares

$146 Million
2.11% of portfolio
Permian Investment Partners, LP New York, NY

12.3M
Shares

$90.7 Million
16.06% of portfolio
Black Creek Investment Management Inc. Toronto, A6

11.1M
Shares

$81.7 Million
3.5% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

10.7M
Shares

$78.9 Million
0.05% of portfolio

View Full List

About Grifols SA

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $4.99B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

More about GRFS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

News

Stay updated on Maven Securities LTD with notifications on news.

Account